M&G PLC

Position in AMGN — Amgen Inc

CIK 1802539 London, X0

Position in AMGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$104,949,256

-$49,535,060 QoQ

Shares Held

289,819

-34.0% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#142

of 3,149 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. AMGN ranks #4 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,482,712	$850,011,848
2	BMY	Bristol Myers Squibb Co	5,292,229	$304,938,234
3	ABBV	AbbVie Inc.	579,447	$145,812,043
4	AMGN	Amgen Inc This page	289,819	$104,949,256
5	MRK	Merck & Co., Inc.	210,965	$27,109,002
6	JNJ	Johnson & Johnson	52,505	$13,334,694
7	PFE	Pfizer Inc	418,626	$10,080,514
8	GILD	Gilead Sciences, Inc.	78,527	$9,921,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$104,949,256	289,819	-34.0%	Shares	Defined	2026-08-06
2026-03-31	$154,484,316	439,063	-4.4%	Shares	Defined	2026-05-13
2025-12-31	$150,363,922	459,393	+1.1%	Shares	Defined	2026-02-12
2025-09-30	$128,283,604	454,584	+3.8%	Shares	Defined	2025-11-07
2025-06-30	$122,276,668	437,938	+4.7%	Shares	Sole	2025-08-08
2025-03-31	$130,299,556	418,230	-5.1%	Shares	Sole	2025-05-13
2024-12-31	$114,897,931	440,830	+55.8%	Shares	Sole	2025-02-11
2024-09-30	$91,190,907	283,017	+676.5%	Shares	Sole	2024-10-31
2024-06-30	$11,388,490	36,449	+35.6%	Shares	Sole	2024-07-16
2024-03-31	$7,641,668	26,877	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.